Companies › SRZN
SURROZEN INC (SRZN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001824893 · EDGAR filings · Updated 2026-07-24
SURROZEN INC (SRZN) has reported institutional ownership of 77.8%, with 58 institutional managers holding positions valued at $258.4M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (2)
- 2026-07-24 — SCHEDULE 13G/A filed
- 2026-07-24 — Insider transaction reported (Form 4)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-06-16 — Insider transaction reported (Form 4)
- 2026-06-16 — Insider transaction reported (Form 4)
- 2026-06-16 — Insider transaction reported (Form 4)
- 2026-06-16 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, SURROZEN INC has 58 institutional holders and institutional ownership of 77.8%.
Insider activity
Insiders reported 66 transactions (56 buys, 2 sells) across 9 reporting insiders, with a net reported value of $16.8M.
Data flags from SEC filings
Related companies
SAB BIOTHERAPEUTICS INC (SABS) · REZOLUTE INC (RZLT) · ORTHOPEDIATRICS CORP (KIDS) · PALISADE BIO INC (PALI) · EIKON THERAPEUTICS INC (EIKN) · Immix Biopharma Inc (IMMX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.